CA2394160A1 - Proteines d'oxydoreductase humaines - Google Patents

Proteines d'oxydoreductase humaines Download PDF

Info

Publication number
CA2394160A1
CA2394160A1 CA002394160A CA2394160A CA2394160A1 CA 2394160 A1 CA2394160 A1 CA 2394160A1 CA 002394160 A CA002394160 A CA 002394160A CA 2394160 A CA2394160 A CA 2394160A CA 2394160 A1 CA2394160 A1 CA 2394160A1
Authority
CA
Canada
Prior art keywords
orp
polynucleotide
polypeptide
sequence
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002394160A
Other languages
English (en)
Inventor
Henry Yue
Preeti Lal
Y. Tom Tang
Jennifer L. Hillman
Mariah R. Baughn
Yalda Azimzai
Dyung Aina M. Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2394160A1 publication Critical patent/CA2394160A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouvelles protéines d'oxydoréductase humaines (ORP) et des polynucléotides identifiant et codant ces ORP. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement ou de prévention de troubles liés à l'expression des ORP.
CA002394160A 1999-12-16 2000-12-07 Proteines d'oxydoreductase humaines Abandoned CA2394160A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17236799P 1999-12-16 1999-12-16
US60/172,367 1999-12-16
PCT/US2000/033158 WO2001044448A2 (fr) 1999-12-16 2000-12-07 Proteines d'oxydoreductase humaines

Publications (1)

Publication Number Publication Date
CA2394160A1 true CA2394160A1 (fr) 2001-06-21

Family

ID=22627426

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002394160A Abandoned CA2394160A1 (fr) 1999-12-16 2000-12-07 Proteines d'oxydoreductase humaines

Country Status (5)

Country Link
EP (1) EP1242583A2 (fr)
JP (1) JP2003516750A (fr)
AU (1) AU2067501A (fr)
CA (1) CA2394160A1 (fr)
WO (1) WO2001044448A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020081679A1 (en) * 1999-10-22 2002-06-27 Millennium Pharmaceuticals, Inc. NARC8 programmed cell-death-associated molecules and uses thereof
WO2002018582A2 (fr) * 2000-08-31 2002-03-07 Millennium Pharmaceuticals, Inc. 62112, nouvelle deshydrogenase humaine et ses utilisations
US6613554B2 (en) 2001-03-26 2003-09-02 Applera Corporation Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof
US20070042361A1 (en) * 2001-03-27 2007-02-22 Rosen Craig A Human secreted proteins
US20050107317A1 (en) * 2002-03-07 2005-05-19 Marcus Geese Cg3842 homologous proteins involved in the regulation of energy homeostasis
JP2005527217A (ja) * 2002-05-27 2005-09-15 バイエル・ヘルスケア・アクチェンゲゼルシャフト 新規なヒトアスパラギンヒドロキシラーゼの調節
WO2004037987A2 (fr) * 2002-10-22 2004-05-06 Incyte Corporation Proteines secretees
US20050031605A1 (en) * 2003-02-03 2005-02-10 Bunn Howard F. Compositions and methods of treating diabetes
WO2004103316A2 (fr) * 2003-05-21 2004-12-02 Xenon Genetics Inc. Nouvelle cible therapeutique orp9 d'augmentation des niveaux de hdl
JP2006527593A (ja) * 2003-06-17 2006-12-07 デヴゲン エヌブイ 代謝性疾患の予防及び／又は治療のための化合物を開発するために有用なアルコールデヒドロゲナーゼ配列
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics

Also Published As

Publication number Publication date
EP1242583A2 (fr) 2002-09-25
WO2001044448A2 (fr) 2001-06-21
AU2067501A (en) 2001-06-25
JP2003516750A (ja) 2003-05-20
WO2001044448A3 (fr) 2002-01-17

Similar Documents

Publication Publication Date Title
CA2408315A1 (fr) Aminoacyl-arnt synthetases
CA2380317A1 (fr) Synthetases humaines
CA2431493A1 (fr) Aminoacyl arnt synthetases
CA2383927A1 (fr) Proteines phosphatase et proteines kinase
CA2394160A1 (fr) Proteines d'oxydoreductase humaines
EP1498480A2 (fr) Enzymes hydrolitiques humaines
CA2387785A1 (fr) Molecules humaines de la transferase
CA2410953A1 (fr) Adenylyl et guanylyl cyclases
CA2398003A1 (fr) Phosphodiesterases
CA2413810A1 (fr) Aminoacyl arnt synthetases
CA2382019A1 (fr) Proteines d'isomerase
CA2374413A1 (fr) Proteines d'oxydoreductase
US20030124106A1 (en) Human oxidoreductase proteins
CA2423701A1 (fr) Oxydoreductases
EP1124951A2 (fr) Tri de nexines
CA2381338A1 (fr) Lyases humaines
CA2401670A1 (fr) Molecules d'enzyme humaine
CA2390689A1 (fr) Lyases humaines et proteines associees
CA2378930A1 (fr) Proteines de transfert d'electrons
CA2425767A1 (fr) Lipocalines
CA2379133A1 (fr) Proteines humaines impliquees dans la detoxification
CA2414010A1 (fr) Proteines redox secretees
EP1477564A2 (fr) Synthetases humaines
CA2406722A1 (fr) Proteines de modification d'adn
CA2441548A1 (fr) Adenylyl et guanylyl cyclases

Legal Events

Date Code Title Description
FZDE Dead